These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 2575021)

  • 1. Review of beta blocker myocardial infarction trials.
    Goldstein S
    Clin Cardiol; 1989 Jul; 12(7 Suppl 3):III54-7. PubMed ID: 2575021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of beta-blockers during and after myocardial infarction.
    Aronow WS
    Compr Ther; 1998; 24(6-7):327-31. PubMed ID: 9669097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-adrenergic blocking agents in the treatment of patients after a myocardial infarction.
    Goldstein S
    Henry Ford Hosp Med J; 1991; 39(3-4):200-5. PubMed ID: 1687143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Necrotic lesions, ischemia and reperfusion: effects of beta blockers].
    Lechat P
    Arch Mal Coeur Vaiss; 1993 Jul; 86 Spec No 4():85-90. PubMed ID: 7905729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial infarction. Effects of beta-blockade.
    Hjalmarson A; Olsson G
    Circulation; 1991 Dec; 84(6 Suppl):VI101-7. PubMed ID: 1683604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relation of mortality to failure to prescribe beta blockers acutely in patients with sustained ventricular tachycardia and ventricular fibrillation following acute myocardial infarction (from the VALsartan In Acute myocardial iNfarcTion trial [VALIANT] Registry).
    Piccini JP; Hranitzky PM; Kilaru R; Rouleau JL; White HD; Aylward PE; Van de Werf F; Solomon SD; Califf RM; Velazquez EJ
    Am J Cardiol; 2008 Dec; 102(11):1427-32. PubMed ID: 19026290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Beta blockade in acute myocardial infarction].
    Bosković D; Terzić B; Perunicić J; Zugić M; Beleslin BD
    Srp Arh Celok Lek; 1992 Jun; 120 Suppl 4():17-24. PubMed ID: 18196643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxprenolol in myocardial infarction survivors: brief review of the European Infarction Study results in the light of other beta-blocker post infarction trials.
    Schröder R
    Z Kardiol; 1985; 74 Suppl 6():165-72. PubMed ID: 2869616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of beta blockers in high-risk patients after myocardial infarction in conjunction with captopril and/or valsartan (from the VALsartan In Acute Myocardial Infarction [VALIANT] trial).
    Califf RM; Lokhnygina Y; Velazquez EJ; McMurray JJ; Leimberger JD; Lewis EF; Diaz R; Murin J; Pfeffer MA
    Am J Cardiol; 2009 Jul; 104(2):151-7. PubMed ID: 19576338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of acute beta-blocker therapy for patients with non-ST-segment elevation myocardial infarction.
    Miller CD; Roe MT; Mulgund J; Hoekstra JW; Santos R; Pollack CV; Ohman EM; Gibler WB; Peterson ED
    Am J Med; 2007 Aug; 120(8):685-92. PubMed ID: 17679127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium antagonists in the therapy of acute myocardial infarction.
    Stazi F; Verde M; Stazi C; Di Gennaro M
    Minerva Cardioangiol; 2000; 48(1-2):29-38. PubMed ID: 10829585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reappraisal of beta-blocker therapy in the acute and chronic post-myocardial infarction period.
    Borrello F; Beahan M; Klein L; Gheorghiade M
    Rev Cardiovasc Med; 2003; 4 Suppl 3():S13-24. PubMed ID: 14564230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-myocardial infarction beta-blocker therapy: the bradycardia conundrum. Rationale and design for the Pacemaker & beta-blocker therapy post-MI (PACE-MI) trial.
    Goldberger JJ; Bonow RO; Cuffe M; Dyer A; Greenland P; Rosenberg Y; O'Rourke R; Shah PK; Smith S
    Am Heart J; 2008 Mar; 155(3):455-64. PubMed ID: 18294477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-blocker underuse in secondary prevention of myocardial infarction.
    Everly MJ; Heaton PC; Cluxton RJ
    Ann Pharmacother; 2004 Feb; 38(2):286-93. PubMed ID: 14742768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of combined beta-blocker and angiotensin-converting enzyme inhibitor treatment on 1-year survival after acute myocardial infarction: findings of the PRIAMHO-II registry].
    Arós F; Loma-Osorio A; Vila J; López-Bescós L; Cuñat J; Rodríguez E; San José JM; Heras M; Marrugat J;
    Rev Esp Cardiol; 2006 Apr; 59(4):313-20. PubMed ID: 16709383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Beta blockers in arrhythmias].
    Fuhrer J
    Praxis (Bern 1994); 1995 Mar; 84(11):304-12. PubMed ID: 7724946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Secondary prophylaxis with beta blockers after myocardial infarction].
    Bosković D
    Srp Arh Celok Lek; 1992 Jun; 120 Suppl 4():25-34. PubMed ID: 18193807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rationale, design and organization of the Second Chinese Cardiac Study (CCS-2): a randomized trial of clopidogrel plus aspirin, and of metoprolol, among patients with suspected acute myocardial infarction. Second Chinese Cardiac Study (CCS-2) Collaborative Group.
    Second Chinese Cardiac Study (CCS-2) Collaborative Group
    J Cardiovasc Risk; 2000 Dec; 7(6):435-41. PubMed ID: 11189013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benefits of non-selective versus cardioselective beta-blockers in acute myocardial infarction in hypertensive patients.
    Hansen O; Johansson BW
    J Hypertens Suppl; 1993 Jun; 11(4):S55-60. PubMed ID: 8104242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Myocardial infarction: secondary prevention with betablockers].
    Depelchin P; Hammoude H; Degré S
    Ann Cardiol Angeiol (Paris); 1989 Mar; 38(3):155-61. PubMed ID: 2567590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.